Histoplasmosis pathophysiology

Jump to navigation Jump to search

Histoplasmosis Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Histoplasmosis from other Diseases

Epidemiology and Demographics

Screening

Risk Factors

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

Chest X Ray

CT

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Case Studies

Case #1

Histoplasmosis pathophysiology On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Histoplasmosis pathophysiology

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Histoplasmosis pathophysiology

CDC on Histoplasmosis pathophysiology

Histoplasmosis pathophysiology in the news

Blogs on Histoplasmosis pathophysiology

Directions to Hospitals Treating Histoplasmosis

Risk calculators and risk factors for Histoplasmosis pathophysiology

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Overview

Pathophysiology

Transmission

  • The areas contaminated with histoplasma microconidia are called microfoci and disturbance of these microfoci will result in exposure to the microconidia.
  • The activities which expose the patient to histoplasma microconidia include farming, exposure to chicken coops or caves and sites where black birds have roosted.
  • Histoplasmosis is typically acquired via inhalation of airborne microconidia, often after disturbance of contaminated material in the soil.
  • In majority of the patients the infection is asymtomatic and resolves with host's immune response. In few patients inhalation of large amount of inoculum can result in an acute pulmonary infection with symptoms resembling pneumonia.
  • The cell mediated immune response is by the T-lymphocytes which recognize the organism and induce the release of cytokines such as tumor necrosis factor alpha and interferon gamma which provide protection aganist re-infection.
  • The release of cytokines activates macrophages which inhibit the growth of the fungus and limit its spread to the surrounding tissue. This results in the formation of a granuloma wherein the fungus is present in a nonviable state.
  • In patients with immunosuppression, they are unable to mount an adequate T-cell mediated immune response resulting in uncontrolled growth of the organism with spread to the surrounding tissue and increasing the morbidity and mortality of the infection.[1]
  • Primary cutaneous histoplasmosis and solid organ donor-derived histoplasmosis have been observed although extremely uncommon.[2]

Gross pathology

Microscopic pathology

References

  1. Edwards JA, Rappleye CA (2011). "Histoplasma mechanisms of pathogenesis--one portfolio doesn't fit all". FEMS Microbiol Lett. 324 (1): 1–9. doi:10.1111/j.1574-6968.2011.02363.x. PMC 3228276. PMID 22092757.
  2. Information for Healthcare Professionals about Histoplasmosis. Centers for Disease Control and Prevention. 2015. Available at: http://www.cdc.gov/fungal/diseases/histoplasmosis/health-professionals.html. Accessed February 2, 2016.